Post-thrombectomy management of the ELVO patient: Guidelines from the Society of NeuroInterventional Surgery

Recent trials have proven the benefits of endovascular treatment for patients with stroke from emergent large vessel occlusions (ELVOs).1–5 Optimal management of these patients involves attention to pre-procedural, intra-procedural, and post-procedural elements. However, many of the ideal treatment approaches following endovascular stroke therapy remain controversial. This document synthesizes current recommendations from the best available evidence to provide guidance in the post-procedural management of a patient undergoing stroke thrombectomy. This document was constructed by the Standards and Guidelines Committee of the Society for NeuroInterventional Surgery, a multidisciplinary committee composed of practitioners with backgrounds including neuroradiology, vascular neurosurgery, stroke neurology, and neurocritical care. We reviewed electronic databases for publications related to the management of acute stroke patients post-procedure, using both broad and narrow search terms. We subsequently evaluated those results for papers with randomized clinical results, which were given the highest priority. The remaining papers were assessed on the basis of individual methodology, and recommendations were made based on the data available. In the absence of supporting adequate clinical trial evidence, the committee made consensus recommendations. Each recommendation is graded, where possible, with a level of evidence utilizing the American Heart Association/American Stroke Association grading system.6 This document represents one of a continuum related to acute stroke intervention, including other documents on prehospital management, training standards for thrombectomy, and management of ELVO patients.7–9 ### Post-thrombectomy care environment ELVO patients require careful monitoring in a stroke unit or intensive care unit. Stroke units provide dedicated, specialized, multidisciplinary inpatient care for ELVO patients. Patients treated in this environment are more likely to survive, regain independence, and return home than those receiving less organized service.10 Stroke units are characterized by protocol guided care, adherence to guidelines, and coordination of care provided by various services.11–14 Furthermore, a dedicated stroke unit is preferable to a mobile consultative …

[1]  J. Peters,et al.  National Institute of Neurological Disorders and Stroke , 2014, Definitions.

[2]  R. Sacco,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. , 2019, Stroke.

[3]  Hester F. Lingsma,et al.  Letter by Mulder et al Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". , 2019, Stroke.

[4]  R. Conwit,et al.  Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy – Magnesium) , 2017, Stroke.

[5]  L. Parker,et al.  Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  J. Mocco,et al.  Prehospital care delivery and triage of stroke with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of Neurointerventional Surgery , 2016, Journal of NeuroInterventional Surgery.

[7]  J. Fraser,et al.  Stroke neuroprotection revisited: Intra-arterial verapamil is profoundly neuroprotective in experimental acute ischemic stroke , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Training Guidelines for Endovascular Ischemic Stroke Intervention: An International multi-society consensus document , 2016, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[9]  London,et al.  Training Guidelines for Endovascular Ischemic Stroke Intervention: An International multi-society consensus document , 2016, Journal of NeuroInterventional Surgery.

[10]  B. Rochwerg,et al.  Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. , 2015, JAMA.

[11]  Daniel E. Ray,et al.  Integrating Palliative Care Into the Care of Neurocritically Ill Patients: A Report From the Improving Palliative Care in the ICU Project Advisory Board and the Center to Advance Palliative Care* , 2015, Critical care medicine.

[12]  M. Chen,et al.  Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery , 2015, Journal of NeuroInterventional Surgery.

[13]  H. Diener,et al.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.

[14]  A. Demchuk,et al.  Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.

[15]  Coleman O. Martin,et al.  Groin complications in endovascular mechanical thrombectomy for acute ischemic stroke: a 10-year single center experience , 2015, Journal of NeuroInterventional Surgery.

[16]  Chin-Hao Chang,et al.  Access site complications following transfemoral coronary procedures: comparison between traditional compression and angioseal vascular closure devices for haemostasis , 2015, BMC Cardiovascular Disorders.

[17]  N. Yamada,et al.  Clinical management provided by board-certificated physiatrists in early rehabilitation is a significant determinant of functional improvement in acute stroke patients: a retrospective analysis of Japan rehabilitation database. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[18]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[19]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[20]  Á. Chamorro,et al.  Relevance of Blood–Brain Barrier Disruption After Endovascular Treatment of Ischemic Stroke: Dual-Energy Computed Tomographic Study , 2015, Stroke.

[21]  J. Mocco,et al.  Prospective series of two hours supine rest after 4fr sheath-based diagnostic cerebral angiography: Outcomes, productivity and cost , 2015, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[22]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[23]  C. Molina,et al.  Early transfer of stroke patients to comprehensive stroke centers: David and Goliath. , 2014, Stroke.

[24]  Rishi Gupta,et al.  Disposition to home or acute rehabilitation is associated with a favorable clinical outcome in the SENTIS trial , 2014, Journal of NeuroInterventional Surgery.

[25]  W. Hacke,et al.  Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. , 2014, The New England journal of medicine.

[26]  A. Demchuk,et al.  Hemicraniectomy and Durotomy Upon Deterioration From Infarction-Related Swelling Trial: Randomized Pilot Clinical Trial , 2014, Stroke.

[27]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[28]  G. Schulte-Altedorneburg,et al.  Hyperattenuated Intracerebral Lesions after Mechanical Recanalization in Acute Stroke , 2014, American Journal of Neuroradiology.

[29]  A. Kastrati,et al.  Bleeding complications in patients undergoing percutaneous coronary interventions: current status and perspective. , 2014, Coronary artery disease.

[30]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  R. Nogueira,et al.  Discharge disposition to skilled nursing facility after endovascular reperfusion therapy predicts a poor prognosis , 2014, Journal of NeuroInterventional Surgery.

[32]  Michael D Hill,et al.  High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial , 2013, The Lancet Neurology.

[33]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[34]  E. Jüttler,et al.  Space-occupying cerebellar infarction: complications, treatment, and outcome. , 2013, Neurosurgical focus.

[35]  B. Walters,et al.  Infection risk in neurointervention and cerebral angiography. , 2013, Neurosurgery.

[36]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[37]  J. Serfaty,et al.  Blood–brain barrier disruption is associated with increased mortality after endovascular therapy , 2013, Neurology.

[38]  K. Furie,et al.  Glyburide is Associated with Attenuated Vasogenic Edema in Stroke Patients , 2013, Neurocritical Care.

[39]  R. Raman,et al.  Comprehensive Stroke Centers and the ‘Weekend Effect’: The SPOTRIAS Experience , 2012, Cerebrovascular Diseases.

[40]  Michael D Hill,et al.  Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial , 2012, The Lancet Neurology.

[41]  J. Simard,et al.  Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas , 2012, Annals of neurology.

[42]  R. Hernández-Clares,et al.  Hemorrhage/Contrast Staining Areas after Mechanical Intra-Arterial Thrombectomy in Acute Ischemic Stroke: Imaging Findings and Clinical Significance , 2012, American Journal of Neuroradiology.

[43]  Mario Zuccarello,et al.  pCO2 and pH regulation of cerebral blood flow , 2012, Front. Physio..

[44]  Yan Zhang,et al.  Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarct: A Randomized Controlled Trial Enrolling Patients up to 80 Years Old , 2012, Neurocritical Care.

[45]  K. Fargen,et al.  Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal , 2012, Journal of NeuroInterventional Surgery.

[46]  F. Rincon Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease , 2012 .

[47]  Ming Liu,et al.  Edaravone for acute ischaemic stroke. , 2011, The Cochrane database of systematic reviews.

[48]  G. Rosenberg,et al.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.

[49]  S. Kasner,et al.  Comprehensive Stroke Centers Overcome the Weekend Versus Weekday Gap in Stroke Treatment and Mortality , 2011, Stroke.

[50]  J. Switzer,et al.  Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke , 2011, Stroke.

[51]  M. Kaste,et al.  Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis , 2011, Neurology.

[52]  H. Diener,et al.  Partial Aortic Occlusion for Cerebral Perfusion Augmentation: Safety and Efficacy of NeuroFlo in Acute Ischemic Stroke Trial , 2011, Stroke.

[53]  J. Chalela,et al.  Osmotherapy: Use Among Neurointensivists , 2011, Neurocritical care.

[54]  H. Kamel,et al.  Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials* , 2011, Critical care medicine.

[55]  T. Videen,et al.  Cerebral Hemodynamic and Metabolic Effects of Equi-Osmolar Doses Mannitol and 23.4% Saline in Patients with Edema Following Large Ischemic Stroke , 2011, Neurocritical care.

[56]  J. Marc Simard,et al.  Novel Treatment Targets for Cerebral Edema , 2011, Neurotherapeutics.

[57]  C. Gerloff,et al.  Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study , 2010, Annals of neurology.

[58]  Christianne Leidecker,et al.  Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining. , 2010, Radiology.

[59]  J. Switzer,et al.  Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study , 2010, Stroke.

[60]  S. Payne,et al.  The palliative care needs of acute stroke patients: a prospective study of hospital admissions. , 2010, Age and ageing.

[61]  M. Jayaraman,et al.  StarClose Vascular Closure Device: Safety and Efficacy of Deployment and Reaccess in a Neurointerventional Radiology Service , 2010, American Journal of Neuroradiology.

[62]  W. Aronow,et al.  Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device. , 2010, The Journal of invasive cardiology.

[63]  J. Álvarez-Sabín,et al.  Monitoring intracranial pressure in patients with malignant middle cerebral artery infarction: is it useful? , 2010, Journal of neurosurgery.

[64]  S. Payne,et al.  End-of-life issues in acute stroke care: a qualitative study of the experiences and preferences of patients and families , 2010, Palliative medicine.

[65]  C. Mazzocato,et al.  The last days of dying stroke patients referred to a palliative care consult team in an acute hospital , 2010, European journal of neurology.

[66]  D. Marion,et al.  Contemporary Management of Traumatic Intracranial Hypertension: Is There a Role for Therapeutic Hypothermia? , 2009, Neurocritical care.

[67]  M. Franceschini,et al.  The Role of the Physiatrist in Stroke Rehabilitation: A European Survey , 2009, American journal of physical medicine & rehabilitation.

[68]  K. Polderman,et al.  Mechanisms of action, physiological effects, and complications of hypothermia , 2009, Critical care medicine.

[69]  A. Algra,et al.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial , 2009, The Lancet Neurology.

[70]  Michael D Hill,et al.  Impact of a Stroke Unit on Length of Hospital Stay and In-Hospital Case Fatality , 2009, Stroke.

[71]  J. Grotta,et al.  Can Comprehensive Stroke Centers Erase the ‘Weekend Effect’? , 2008, Cerebrovascular Diseases.

[72]  D. Manawadu,et al.  Hemicraniectomy for Massive Middle Cerebral Artery Infarction: A Review , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[73]  R. Geocadin,et al.  Reversal of transtentorial herniation with hypertonic saline , 2008, Neurology.

[74]  A. Rabinstein Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm , 2008 .

[75]  B. Meyer,et al.  Effect of Endovascular Hypothermia on Acute Ischemic Edema: Morphometric Analysis of the ICTuS Trial , 2008, Neurocritical care.

[76]  S. Schwab,et al.  Antiedema Therapy in Ischemic Stroke , 2007, Stroke.

[77]  W. Hacke,et al.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): A Randomized, Controlled Trial , 2007, Stroke.

[78]  I. Janszky,et al.  Weekend versus weekday admission and stroke outcome in Sweden from 1968 to 2005. , 2007, Stroke.

[79]  E. Vicaut,et al.  Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial) , 2007, Stroke.

[80]  U. Dirnagl,et al.  Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke , 2007, Stroke.

[81]  J. Saver Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm , 2007, Stroke.

[82]  W. Poon,et al.  SYMPTOMATIC AUTOREGULATORY FAILURE IN ACUTE ISCHEMIC STROKE , 2007, Neurology.

[83]  Gustavo Saposnik,et al.  Weekends: A Dangerous Time for Having a Stroke? , 2007, Stroke.

[84]  E. Vicaut,et al.  Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials , 2007, Lancet Neurology.

[85]  T. Videen,et al.  Symptomatic autoregulatory failure in acute ischemic stroke , 2007, Neurology.

[86]  Werner Hacke,et al.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study , 2007, The Lancet.

[87]  Peter Langhorne,et al.  Organised inpatient (stroke unit) care for stroke. , 2007, The Cochrane database of systematic reviews.

[88]  J. Hauw,et al.  Predictors for malignant middle cerebral artery infarctions , 2006, Neurology.

[89]  J. Ormiston,et al.  Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation. , 2006, The American journal of cardiology.

[90]  B. Norrving,et al.  The Swedish Malignant Middle cerebral artery Infarction Study: long‐term results from a prospective study of hemicraniectomy combined with standardized neurointensive care , 2006, Acta neurologica Scandinavica.

[91]  J. Kassubek,et al.  Safety and Therapeutical Benefit of Hemicraniectomy Combined with Mild Hypothermia in Comparison with Hemicraniectomy Alone in Patients with Malignant Ischemic Stroke , 2006, Cerebrovascular Diseases.

[92]  R. Geocadin,et al.  Safety of induced hypertension therapy in patients with acute ischemic stroke , 2006, Neurocritical care.

[93]  W. K. D. Paula Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. , 2005, Neurology.

[94]  A. Thrift,et al.  Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? , 2005, Cerebrovascular Diseases.

[95]  R. Shaw,et al.  Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[96]  G. Ekuklu,et al.  Factors affecting the outcome of decompressive craniectomy for large hemispheric infarctions: a prospective cohort study , 2005, Acta Neurochirurgica.

[97]  M. Edwards,et al.  Trial , 2004, The Lancet.

[98]  Jan Sobesky,et al.  Identifying Thresholds for Penumbra and Irreversible Tissue Damage , 2004, Stroke.

[99]  K. Furie,et al.  Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.

[100]  S. Warach,et al.  Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption , 2004, Stroke.

[101]  P. Nightingale,et al.  The effects of position on oxygen saturation in acute stroke: a systematic review , 2004, Clinical rehabilitation.

[102]  D. Krieger,et al.  Cooling for Acute Ischemic Brain Damage (COOL AID) , 2004, Neurology.

[103]  M. Hartmann,et al.  Does acute occlusion of the carotid T invariably have a poor outcome? , 2004, Neurology.

[104]  D. Hasan,et al.  Clinical Course and Surgical Management of Massive Cerebral Infarction , 2004, Neurosurgery.

[105]  R. Baumgartner,et al.  Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke , 2004, Neurology.

[106]  C. Parvin,et al.  Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations , 2004, Critical care medicine.

[107]  M. Müllner,et al.  Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.

[108]  S. Mayer,et al.  Optimizing blood pressure in neurological emergencies , 2004, Neurocritical care.

[109]  Albert van der Zwan,et al.  Anatomy and Functionality of Leptomeningeal Anastomoses: A Review , 2003, Stroke.

[110]  J. Ulatowski,et al.  A Pilot Randomized Trial of Induced Blood Pressure Elevation: Effects on Function and Focal Perfusion in Acute and Subacute Stroke , 2003, Cerebrovascular Diseases.

[111]  H. Dieterich,et al.  Influence of a Long-Term, High-Dose Volume Therapy with 6% Hydroxyethyl Starch 130/0.4 or Crystalloid Solution on Hemodynamics, Rheology and Hemostasis in Patients with Acute Ischemic Stroke , 2003, Pathophysiology of Haemostasis and Thrombosis.

[112]  C. Ayata,et al.  Timing of neurologic deterioration in massive middle cerebral artery infarction: A multicenter review , 2003, Critical care medicine.

[113]  J. Serena,et al.  Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke , 2003, Stroke.

[114]  H. Dieterich,et al.  Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. , 2003, Pathophysiology of haemostasis and thrombosis.

[115]  K. Asplund,et al.  Haemodilution for acute ischaemic stroke. , 2002, The Cochrane database of systematic reviews.

[116]  StefanSchwarz,et al.  Effects of Induced Hypertension on Intracranial Pressure and Flow Velocities of the Middle Cerebral Arteries in Patients With Large Hemispheric Stroke , 2002 .

[117]  P. Riggs,et al.  Management of Infected Femoral Closure Devices , 2002, Cardiovascular surgery.

[118]  Stefan Schwab,et al.  Effects of Body Position on Intracranial Pressure and Cerebral Perfusion in Patients With Large Hemispheric Stroke , 2002, Stroke.

[119]  G. Cherr,et al.  Infection is an Unusual But Serious Complication of a Femoral Artery Catheterization Site Closure Device , 2001, Annals of vascular surgery.

[120]  F. Buonanno,et al.  A pilot study of drug-induced hypertension for treatment of acute stroke , 2001, Neurology.

[121]  J. Koziol,et al.  Suboptimum hemicraniectomy as a cause of additional cerebral lesions in patients with malignant infarction of the middle cerebral artery. , 2001, Journal of neurosurgery.

[122]  S. Lewington,et al.  Corticosteroids for acute ischaemic stroke. , 2002, The Cochrane database of systematic reviews.

[123]  E. Wijdicks,et al.  Neuroimaging in Deteriorating Patients With Cerebellar Infarcts and Mass Effect , 2000, Stroke.

[124]  D. Baim,et al.  Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. , 2000, The American journal of cardiology.

[125]  J. Schramm,et al.  Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study , 1999, Journal of Neurology.

[126]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[127]  W. Hacke,et al.  Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. , 1998, Stroke.

[128]  S. Slørdahl,et al.  Stroke unit treatment improves long-term quality of life: a randomized controlled trial. , 1998, Stroke.

[129]  J. Bogousslavsky,et al.  Large infarcts in the middle cerebral artery territory Etiology and outcome patterns , 1998, Neurology.

[130]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[131]  O. Rønning,et al.  Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial. , 1998, Stroke.

[132]  W Hacke,et al.  Barbiturate coma in severe hemispheric stroke , 1997, Neurology.

[133]  T. N. t-P. S. S. Group,et al.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.

[134]  W. Hacke,et al.  'Malignant' middle cerebral artery territory infarction : Clinical course and prognostic signs , 1996 .

[135]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[136]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[137]  J. Frank Large hemispheric infarction, deterioration, and intracranial pressure , 1995, Neurology.

[138]  W. Schaper,et al.  Collateral Circulation , 1993, Springer US.

[139]  R. Myers,et al.  Hemorrhagic infarct conversion in experimental stroke. , 1992, Annals of emergency medicine.

[140]  V. Marder,et al.  Thrombolytic therapy: current status (2). , 1988, The New England journal of medicine.

[141]  V. Marder,et al.  Thrombolytic therapy: current status (1). , 1988, The New England journal of medicine.

[142]  V. Hachinski,et al.  Early Mortality Following Stroke: A Prospective Review , 1984, Stroke.

[143]  B. Siesjö,et al.  Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.

[144]  T. Simon,et al.  Thrombolytic therapy: Current status. , 1975, The New England journal of medicine.